Last reviewed · How we verify
NCT06845462
Application of Artificial Intelligence Algorithm Based on CT Imaging for Muscle Parameter Measurement
trial in Deep Learning in 1,080 participants. Completed in 31 December 2024.
31 December 2024
Quick facts
| Lead sponsor | RenJi Hospital |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 1,080 |
| Start date | 5 September 2023 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across China |
Conditions studied
- Deep Learning — all drugs for Deep Learning →
- Sarcopenia — all drugs for Sarcopenia →
- Computed Tomography — all drugs for Computed Tomography →
- Body Composition — all drugs for Body Composition →
Sponsor
RenJi Hospital
Who can join
Adults 18 to 90, any sex, with Deep Learning or Sarcopenia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To establish an artificial intelligence model for automated diagnosis of sarcopenia based on CT imaging
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06845462
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Deep Learning
Currently open trials in the same condition.
- NCT07127939 — Diagnostic Performance of an AI-based Model for TCM Constitution Classification Using Ophthalmic Imaging · recruiting
- NCT07146737 — Predictive Performance of a Generative Model for Corneal Tomography After ICL Implantation · recruiting
- NCT07111364 — Construction of a Deep Learning-Based Precise Diagnostic Framework for Bladder Tumors Using Ultrasound: A Multicenter, A · recruiting
- NCT06910956 — Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT · NA · recruiting
- NCT06972043 — AI-Assisted Smart Interactive Healthcare Robot · NA · recruiting
Other RenJi Hospital trials
Trials by the same sponsor.
- NCT07584733 — Biomarker-Enriched Kidney-Preserving Strategy With Disitamab Vedotin Plus Tislelizumab in HER2-Positive High-Risk Upper · Phase 2 · not yet recruiting
- NCT07537725 — EEG-TMS for Postoperative Delirium After Cardiac Surgery · NA · not yet recruiting
- NCT07527936 — A Study of BEN301 Injection in theTreatment of Autoimmune Diseases · EARLY_PHASE1 · not yet recruiting
- NCT07343076 — Efficacy of Immediate Versus Staged Complete Revascularization in Patients With NSTE-ACS and Multivessel Disease (FUTURE · NA · not yet recruiting
- NCT07449793 — Biochemical Response and Clinical Outcomes in Patients With PBC · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06845462 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by RenJi Hospital
- Last refreshed: 25 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06845462.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing